R L Silverstein, R L Nachman. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsArteriosclerosis/drug therapyCD36 Antigens/physiologyMiceNeovascularization, Pathologic/drug therapyThrombospondin 1/physiologyThrombospondin 1/therapeutic use
Substances: See more » CD36 AntigensThrombospondin 1
Year: 1999 PMID: 10458710 DOI: 10.1161/01.cir.100.8.783
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690